Clayton Russell
Insider CIK 1530072 · LRMR Chief Medical Officer · DSCO Senior VP, R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2026-01-26 | 2026-01-27 | 153,822 | — | $0 | 153,822 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award | 2026-01-26 | 2026-01-27 | 25,637 | — | $0 | 71,443 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2025-01-22 | 2025-01-24 | 139,838 | — | $0 | 139,838 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award | 2025-01-22 | 2025-01-24 | 23,306 | — | $0 | 45,806 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2024-01-17 | 2024-01-19 | 135,000 | — | $0 | 135,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award | 2024-01-17 | 2024-01-19 | 22,500 | — | $0 | 22,500 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2023-07-17 | 2023-07-18 | 180,000 | — | $0 | 180,000 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2014-03-06 | 2014-03-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2014-03-06 | 2014-03-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2013-03-26 | 2013-03-28 | 95,876 | — | $0 | 95,876 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2013-03-26 | 2013-03-28 | 54,124 | — | $0 | 54,124 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2012-05-04 | 2012-05-08 | 44,193 | — | $0 | 44,193 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award deriv | 2012-05-04 | 2012-05-08 | 35,807 | — | $0 | 35,807 | SEC↗ |
| DSCO DISCOVERY LABORATORIES INC | A Award | 2012-03-31 | 2012-05-08 | 1,586 | $2.68 | $4.3K | 4,232 | SEC↗ |